Literature DB >> 24951497

Intestinal adaptations in chronic kidney disease and the influence of gastric bypass surgery.

Marguerite Hatch1.   

Abstract

Studies have shown that compensatory adaptations in gastrointestinal oxalate transport can impact the amount of oxalate excreted by the kidney. Hyperoxaluria is a major risk factor in the formation of kidney stones, and oxalate is derived from both the diet and the liver metabolism of glyoxylate. Although the intestine generally absorbs oxalate from dietary sources and can contribute as much as 50% of urinary oxalate, enteric oxalate elimination plays a significant role when renal function is compromised. While the mechanistic basis for these changes in the direction of intestinal oxalate movements in chronic renal failure involves an upregulation of angiotensin II receptors in the large intestine, enteric secretion/excretion of oxalate can also occur by mechanisms that are independent of angiotensin II. Most notably, the commensal bacterium Oxalobacter sp. interacts with the host enterocyte and promotes the movement of oxalate from the blood into the lumen, resulting in the beneficial effect of significantly lowering urinary oxalate excretion. Changes in the passive permeability of the intestine, such as in steatorrhoea and following gastric bypass, also promote oxalate absorption and hyperoxaluria. In summary, this report highlights the two-way physiological signalling between the gut and the kidney, which may help to alleviate the consequences of certain kidney diseases.
© 2014 The Author. Experimental Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24951497      PMCID: PMC4629826          DOI: 10.1113/expphysiol.2014.078782

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  29 in total

1.  Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice.

Authors:  Robert W Freel; Marguerite Hatch; Mike Green; Manoocher Soleimani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-22       Impact factor: 4.052

2.  A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.

Authors:  Alyssa M Park; Douglas W Storm; Brant R Fulmer; Christopher D Still; G Craig Wood; James E Hartle
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

Review 3.  Alterations in intestinal transport of oxalate in disease states.

Authors:  M Hatch; R W Freel
Journal:  Scanning Microsc       Date:  1995

4.  Transcellular oxalate and Cl- absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate.

Authors:  Robert W Freel; Jonathan M Whittamore; Marguerite Hatch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

5.  Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.

Authors:  Marguerite Hatch; Altin Gjymishka; Eduardo C Salido; Milton J Allison; Robert W Freel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-16       Impact factor: 4.052

6.  Factors related to colonization with Oxalobacter formigenes in U.S. adults.

Authors:  Judith Parsells Kelly; Gary C Curhan; David R Cave; Theresa E Anderson; David W Kaufman
Journal:  J Endourol       Date:  2011-03-07       Impact factor: 2.942

7.  Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.

Authors:  Benjamin K Canales; Joseph Ellen; Saeed R Khan; Marguerite Hatch
Journal:  J Urol       Date:  2013-03-14       Impact factor: 7.450

Review 8.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

9.  Increased colonic sodium absorption in rats with chronic renal failure is partially mediated by AT1 receptor agonism.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-06-05       Impact factor: 4.052

10.  Prevalence of hyperoxaluria after bariatric surgery.

Authors:  Bhavin N Patel; Corey M Passman; Adolfo Fernandez; John R Asplin; Fredric L Coe; Sam C Kim; James E Lingeman; Dean G Assimos
Journal:  J Urol       Date:  2008-11-14       Impact factor: 7.450

View more
  9 in total

1.  miR-125a-5p: a novel regulator of SLC26A6 expression in intestinal epithelial cells.

Authors:  Arivarasu N Anbazhagan; Shubha Priyamvada; Alip Borthakur; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2019-05-01       Impact factor: 4.249

2.  The effects of drinking bicarbonate-rich mineral water in calcium oxalate stone formers: an open label prospective randomized controlled study in an Asian cohort.

Authors:  Yadong Lu; Palaniappan Sundaram; HuiHua Li; Tsung Wen Chong
Journal:  Int Urol Nephrol       Date:  2022-07-04       Impact factor: 2.266

Review 3.  Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.

Authors:  Ross P Holmes; John Knight; Dean G Assimos
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

Review 4.  Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?

Authors:  Ammon B Peck; Benjamin K Canales; Cuong Q Nguyen
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

5.  Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.

Authors:  Jonathan M Whittamore; Christine E Stephens; Marguerite Hatch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-01       Impact factor: 4.052

6.  A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.

Authors:  Dawn Milliner; Bernd Hoppe; Jaap Groothoff
Journal:  Urolithiasis       Date:  2017-07-17       Impact factor: 3.436

7.  The role of NHE3 (Slc9a3) in oxalate and sodium transport by mouse intestine and regulation by cAMP.

Authors:  Christine E Stephens; Jonathan M Whittamore; Marguerite Hatch
Journal:  Physiol Rep       Date:  2021-04

8.  Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.

Authors:  Matthew R D'Costa; Annamaria T Kausz; Kevin J Carroll; Jóhann P Ingimarsson; Felicity T Enders; Kristin C Mara; Ramila A Mehta; John C Lieske
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

Review 9.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.